References
- Al-Ahmad MM, Amir N, Dhanasekaran S, et al. (2017). Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis. PLoS One 12:e0183424.
- Altayli E, Gunes S, Yilmaz AF, et al. (2009). CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41:259–66.
- Anwarullah A, Aslam M, Badshah M, Abbasi R, et al. (2017). Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control study. Genes Environ 39:18.
- Aydemir B, Onaran I, Kiziler AR, et al. (2007). Increased oxidative damage of sperm and seminal plasma in men with idiopathic infertility is higher in patients with glutathione S-transferase Mu-1 null genotype. Asian J Androl 9:108–15.
- Aydos SE, Taspinar M, Sunguroglu A, Aydos K. (2009). Association of CYP1A1 and glutathione S-transferase polymorphisms with male factor infertility. Fertil Steril 92:541–7.
- Bageman E, Ingvar C, Rose C, Jernstrom H. (2008). Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer. Epidemiol Biomarkers Prev 17:895–901.
- Bonde JP, Giwercman A. (2014). Environmental xenobiotics and male reproductive health. Asian J Androl 16:3–4.
- Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. (1992). Evidence for decreasing quality of semen during past 50 years. BMJ 305:609–13.
- Cooper TG, Noonan E, VON Eckardstein S, et al. (2010). World Health Organization reference values for human semen characteristics. Hum Reprod Update 16:231–45.
- Croom E. (2012). Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci 112:31–88.
- Faniband M, Lindh CH, Jonsson BA. (2014). Human biological monitoring of suspected endocrine-disrupting compounds. Asian J Androl 16:5–16.
- Guest N, Corey P, Vescovi J, EL-Sohemy A. (2018). Caffeine, CYP1A2 genotype, and endurance performance in athletes. Med Sci Sports Exerc 50:1570–8.
- Gunes S, Metin Mahmutoglu A, Arslan MA, Henkel R. (2018). Smoking-induced genetic and epigenetic alterations in infertile men. Andrologia 50:e13124.
- Hanson BM, Eisenberg ML, Hotaling JM. (2018). Male infertility: a biomarker of individual and familial cancer risk. Fertil Steril 109:6–19.
- Harlev A, Agarwal A, Gunes SO, et al. (2015). Smoking and male infertility: an evidence-based review. World J Mens Health 33:143–60.
- Huang XK, Huang YH, Huang JH, Liang JY. (2017). Glutathione S-transferase P1 Ile105Val polymorphism and male infertility risk: an updated meta-analysis. Chin Med J (Engl) 130:979–85.
- Idle JR, Gonzalez FJ. (2007). Metabolomics. Cell Metab 6:348–51.
- Jaiswal D, Sah R, Agrawal NK, et al. (2012). Combined effect of GSTT1 and GSTM1 polymorphisms on human male infertility in north Indian population. Reprod Sci 19:312–6.
- Kolesnikova LI, Kurashova NA, Bairova TA, et al. (2017a). Role of glutathione-S-transferase family genes in male infertility. Bull Exp Biol Med 163:643–5.
- Kolesnikova LI, Kurashova NA, Bairova TA, et al. (2017b). Features of lipoperoxidation, antioxidant defense, and thiol/disulfide system in the pathogenesis of infertility in males, carriers of nonfunctional variants of GSTT1 and GSTM1 gene polymorphisms. Bull Exp Biol Med 163:378–80.
- Levine H, Jorgensen N, Martino-Andrade A, et al. (2017). Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update 23:646–59.
- Mcilwain CC, Townsend DM, Tew KD. (2006). Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 25:1639–48.
- Miller SA, Dykes DD, Polesky HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
- Nebert DW, Vasiliou V. (2004). Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics 1:460–4.
- Olsen J, Ramlau-Hansen CH. (2014). Epidemiologic methods for investigating male fecundity. Asian J Androl 16:17–22.
- Pacchierotti F, Eichenlaub-Ritter U. (2011). Environmental hazard in the aetiology of somatic and germ cell aneuploidy. Cytogenet Genome Res 133:254–68.
- Polimanti R, Piacentini S, Fuciarelli M. (2011). HapMap-based study of human soluble glutathione S-transferase enzymes: the role of natural selection in shaping the single nucleotide polymorphism diversity of xenobiotic-metabolizing genes. Pharmacogenet Genomics 21:665–72.
- Safarinejad MR, Dadkhah F, Ali Asgari M, et al. (2012). Glutathione S-transferase polymorphisms (GSTM1, GSTT1, GSTP1) and male factor infertility risk: a pooled analysis of studies. Urol J 9:541–8.
- Safarinejad MR, Shafiei N, Safarinejad S. (2010). The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility. J Hum Genet 55:565–70.
- Simon L, Emery BR, Carrell DT. (2017). Review: diagnosis and impact of sperm DNA alterations in assisted reproduction. Best Pract Res Clin Obstet Gynaecol 44:38–56.
- Stearns G, Turek PJ. (2013). Avoiding toxins including spermatotoxic medications. Semin Reprod Med 31:286–92.
- Vistisen K, Loft S, Olsen JH, et al. (2004). Low CYP1A2 activity associated with testicular cancer. Carcinogenesis 25:923–9.
- Volk M, Jaklic H, Zorn B, Peterlin B. (2011). Association between male infertility and genetic variability at the PON1/2 and GSTM1/T1 gene loci. Reprod Biomed Online 23:105–10.
- Xiong DK, Chen HH, Ding XP, et al. (2015). Association of polymorphisms in glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) with idiopathic azoospermia or oligospermia in Sichuan, China. Asian J Androl 17:481–6.
- Yarosh SL, Kokhtenko EV, Churnosov MI, et al. (2015). Joint effect of glutathione S-transferase genotypes and cigarette smoking on idiopathic male infertility. Andrologia 47:980–6.
- Yu B, Huang Z. (2015). Variations in antioxidant genes and male infertility. Biomed Res Int 2015:513196.
- Zalata A, EL-Samanoudy AZ, Osman G, et al. (2015). Cytochrome P450-2D6*4 polymorphism seminal relationship in infertile men. Andrologia 47:525–30.
- Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41.